Advanced Medical Solutions Group (LON:AMS) Shares Pass Above 200 Day Moving Average – Here’s Why

Advanced Medical Solutions Group plc (LON:AMS) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 213.35 and traded as high as GBX 219.25. Advanced Medical Solutions Group shares last traded at GBX 215.50, with a volume of 555,265 shares.

Analysts Set New Price Targets

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research note on Thursday, January 15th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Advanced Medical Solutions Group has an average rating of “Buy” and a consensus target price of GBX 273.67.

Advanced Medical Solutions Group Stock Performance

The stock’s 50-day moving average price is GBX 216.79 and its 200 day moving average price is GBX 213.35. The company has a quick ratio of 4.58, a current ratio of 8.39 and a debt-to-equity ratio of 37.01. The company has a market cap of £466.25 million, a P/E ratio of 51.68, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.